These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 12165466)

  • 1. Inflammation in neurodegenerative disease--a double-edged sword.
    Wyss-Coray T; Mucke L
    Neuron; 2002 Aug; 35(3):419-32. PubMed ID: 12165466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
    Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
    Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between neuroinflammation and neurodegenerative diseases].
    Qiu AW; Liu Z; Guo J; Peng YP
    Sheng Li Ke Xue Jin Zhan; 2011 Oct; 42(5):353-8. PubMed ID: 22242402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution-Associated Molecular Patterns (RAMPs) as Endogenous Regulators of Glia Functions in Neuroinflammatory Disease.
    Wenzel TJ; Kwong E; Bajwa E; Klegeris A
    CNS Neurol Disord Drug Targets; 2020; 19(7):483-494. PubMed ID: 32614758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
    Tian YY; An LJ; Jiang L; Duan YL; Chen J; Jiang B
    Life Sci; 2006 Dec; 80(3):193-9. PubMed ID: 17049947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.
    Gasque P; Neal JW; Singhrao SK; McGreal EP; Dean YD; Van BJ; Morgan BP
    Mol Neurobiol; 2002 Feb; 25(1):1-17. PubMed ID: 11890454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain.
    Griffiths MR; Gasque P; Neal JW
    J Neuropathol Exp Neurol; 2009 Mar; 68(3):217-26. PubMed ID: 19225414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimmune Crosstalk through Extracellular Vesicles in Health and Disease.
    Delpech JC; Herron S; Botros MB; Ikezu T
    Trends Neurosci; 2019 May; 42(5):361-372. PubMed ID: 30926143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron-microglia interaction in neuroinflammation.
    Suzumura A
    Curr Protein Pept Sci; 2013 Feb; 14(1):16-20. PubMed ID: 23544747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.
    Wilms H; Zecca L; Rosenstiel P; Sievers J; Deuschl G; Lucius R
    Curr Pharm Des; 2007; 13(18):1925-8. PubMed ID: 17584117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages at CNS interfaces: ontogeny and function in health and disease.
    Kierdorf K; Masuda T; Jordão MJC; Prinz M
    Nat Rev Neurosci; 2019 Sep; 20(9):547-562. PubMed ID: 31358892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
    Barrette B; Nave KA; Edgar JM
    Biol Chem; 2013 Dec; 394(12):1571-81. PubMed ID: 23959664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphic visualization of inflammation in neurodegenerative disorders.
    Versijpt J; Van Laere K; Dierckx RA; Dumont F; De Deyn PP; Slegers G; Korf J
    Nucl Med Commun; 2003 Feb; 24(2):209-21. PubMed ID: 12548046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative disorders and sterile inflammation: lessons from a Drosophila model.
    Nainu F; Salim E; Asri RM; Hori A; Kuraishi T
    J Biochem; 2019 Sep; 166(3):213-221. PubMed ID: 31251338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenic role of the inflammasome in neurodegenerative diseases.
    Freeman LC; Ting JP
    J Neurochem; 2016 Jan; 136 Suppl 1():29-38. PubMed ID: 26119245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation: good, bad, or indifferent?
    Kielian T
    J Neurochem; 2014 Jul; 130(1):1-3. PubMed ID: 24861635
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperglycemia-Induced Oxidative-Nitrosative Stress Induces Inflammation and Neurodegeneration via Augmented Tuberous Sclerosis Complex-2 (TSC-2) Activation in Neuronal Cells.
    Kumar P; Raman T; Swain MM; Mishra R; Pal A
    Mol Neurobiol; 2017 Jan; 54(1):238-254. PubMed ID: 26738854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection.
    van Beek J; Elward K; Gasque P
    Ann N Y Acad Sci; 2003 May; 992():56-71. PubMed ID: 12794047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of neuroinflammation: Role and therapeutic potential of TRPV1 in the neuro-immune axis.
    Kong WL; Peng YY; Peng BW
    Brain Behav Immun; 2017 Aug; 64():354-366. PubMed ID: 28342781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death.
    Neher JJ; Neniskyte U; Zhao JW; Bal-Price A; Tolkovsky AM; Brown GC
    J Immunol; 2011 Apr; 186(8):4973-83. PubMed ID: 21402900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.